LongTaal

27/05/2019

: Rare Disease Clinical Research Untapped potential in MENA

Due to the small population size and geographic spread of individual rare diseases, in requires a tailored approach to overcome these obstacles and still contain costs and shorten timelines. With over 900 common identified, state-of-the art facilities and regulatory processes in line with international standards, the Middle East, North Africa ( ) region has the potential to contribute greatly to the advancement of rare disease research. Since 2008, the global top 10 Pharmaceutical industry sponsors in rare disease research have collectively conducted more than 70 rare disease studies in the region. Clearly the is available, only the potential has yet to be further utilized.

Read more and get your PDF copy of the paper here: http://longtaal.com/ltresearch-rare-disease-clinical-research-untapped-potential-in-mena/

Due to the small population size and geographic spread of...

25/09/2017

: How well do you know the clinical trial environment? In which of the following countries do patients have the highest accessibility to Biopharma Industry R&D clinical trials (expressed in terms of active BPCT clinical trials per 1million population)? This and much more in our latest . Signup to our bi-monthly newsletters here: http://eepurl.com/c4Hdz5

http://longtaal.com/ltfact-highest-accessibility-biopharma-industry-rd-clinical-trials/

How well do you know the clinical trial environment? In which...

22/05/2017

Was good to see many old friends and make some new friends at Clinical Trials in Central and Eastern Europe in Budapest. Based on the results released at the conference by the LongTaal Institute, 19 years after the start of globalization of clinical trials CEE as a region is enjoying highest reputation among sponsors of industry R&D clinical trials. Pls visit www.longtaal.com if you would like to learn more.

03/04/2017

LONGTAAL - THE CLINICAL TRIAL ANALYTICS COMPANY
was founded in 2012 by a small team of experts in research and development. We help government policy-makers, medical institutions, biopharmaceutical companies and contract research organizations gain an easy access to information about industry-sponsored .
Find out more: http://longtaal.com/longtaal-provides-industrys-first-class-clinical-trials-intelligence/

LongTaal provides the industry’s first class clinical trials intelligence, enabling pharma...

12/07/2016

: Accessibility to clinical trials is 1.3x lower in Saudi Arabia than in Egypt and 16x lower than in Turkey. LongTaal